Bartynski W S, Lin L
Department of Radiology, Western Pennsylvania Hospital, Pittsburgh 15224, USA.
AJNR Am J Neuroradiol. 1997 May;18(5):965-72.
To determine whether dynamic traditional spin-echo MR imaging, with the use of routine T1 parameters during contrast infusion, is superior to standard MR imaging after contrast administration for detecting microlesions of the pituitary gland.
Sixty-four patients with pituitary microlesions 3 to 10 mm in diameter were examined with a dynamic traditional spin-echo technique; that is, a typical T1 spin-echo sequence of 500-600/20-25/2 (repetition time/echo time/excitations), 3-mm-thick sections, 16-cm field of view, 256 x 128 matrix, and a scan time ranging from 2 minutes to 2 minutes 40 seconds during contrast infusion. In addition, standard imaging with unenhanced and contrast-enhanced spin-echo sequences were obtained. The three sequences were evaluated retrospectively and graded for gland-lesion contrast conspicuity, lesion homogeneity, and delineation of lesion margin.
The dynamic sequence was judged to be better than the standard enhanced sequence for depicting microlesions in 42% to 47% of patients. Lesions were identified only on the dynamic study in an additional 1% to 14% of patients. Lesions were seen equally well on the standard and dynamic sequences only in 16% to 23% of cases. The standard postcontrast sequence was judged better in 12.5% to 17% of cases, with lesions identified only on the standard sequence in an additional 8% to 9%.
Dynamic traditional spin-echo MR imaging improved lesion detection and provided increased clarity over standard sequences after contrast infusion. Both sequences are important, since lesions were detected only on the dynamic sequence in 11% to 14% of patients and only on the standard sequence in 8% to 9% of patients.
确定在静脉注射造影剂期间使用常规T1参数的动态传统自旋回波磁共振成像(MR成像)在检测垂体微病变方面是否优于造影剂注射后的标准MR成像。
对64例直径为3至10毫米的垂体微病变患者采用动态传统自旋回波技术进行检查;即采用典型的T1自旋回波序列,参数为500 - 600/20 - 25/2(重复时间/回波时间/激励次数),层厚3毫米,视野16厘米,矩阵256×128,在静脉注射造影剂期间扫描时间为2分钟至2分40秒。此外,还获得了未增强和增强自旋回波序列的标准成像。对这三个序列进行回顾性评估,并根据腺体 - 病变对比清晰度、病变均匀性和病变边缘清晰度进行分级。
在42%至47%的患者中,动态序列在描绘微病变方面被判定优于标准增强序列。在另外1%至14%的患者中,仅在动态研究中发现病变。仅在16%至23%的病例中,标准序列和动态序列对病变的显示效果相同。在12.5%至17%的病例中,标准增强后序列被判定更好,另外8%至9%的病例中仅在标准序列上发现病变。
动态传统自旋回波MR成像改善了病变检测,并在静脉注射造影剂后比标准序列提供了更高的清晰度。两个序列都很重要,因为在11%至14%的患者中仅在动态序列上检测到病变,而在8%至9%的患者中仅在标准序列上检测到病变。